These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1152675)

  • 21. The effects of an oral combined contraceptive on plasma levels of glucose, free fatty acids, glycerol, D- hydroxybutyrate and triglycerides.
    Lunell NO; Persson B; Ohqvist G
    Acta Obstet Gynecol Scand; 1973; 52(1):23-4. PubMed ID: 4688539
    [No Abstract]   [Full Text] [Related]  

  • 22. Norethindrone acetate inhibition of splanchnic triglyceride secretion in conscious glucose-fed siwne.
    Wolfe BM; Grace DM
    J Lipid Res; 1979 Feb; 20(2):175-82. PubMed ID: 438659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glucose and insulin levels after six months of treatment with a triphasic oral contraceptive containing ethinyl estradiol and norethindrone.
    Spellacy WN; Ellingson AB; Tsibris JC
    J Reprod Med; 1989 Aug; 34(8):540-2. PubMed ID: 2681750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucagon secretion in primary endogenous hypertriglyceridemia before and after clofibrate treatment.
    Tiengo A; Muggeo M; Assan R; Fedele D; Crepaldi G
    Metabolism; 1975 Aug; 24(8):901-14. PubMed ID: 1143089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of some contraceptive steroids on serum proteins of women.
    Briggs M; Briggs M
    Biochem Pharmacol; 1973 Sep; 22(18):2277-81. PubMed ID: 4733678
    [No Abstract]   [Full Text] [Related]  

  • 27. The ultrastructure of liver cells in women under steroid therapy. II. Contraceptive therapy.
    Martínez-Manautou J; Aznar-Ramos R; Bautista-O'Farrill J; González-Angulo A
    Acta Endocrinol (Copenh); 1970 Oct; 65(2):207-21. PubMed ID: 4097029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modifications in the menstrual pattern during use of hormonal contraceptives].
    de Sampaio LF; Novo NF; de Paiva ER
    Matern Infanc (Sao Paulo); 1974; 33(3):367-70. PubMed ID: 4466962
    [No Abstract]   [Full Text] [Related]  

  • 29. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives.
    Damber MG; von Schoultz B; Solheim F; Stigbrand T
    Am J Obstet Gynecol; 1976 Feb; 124(3):289-92. PubMed ID: 55075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decreased liver cytochrome P-450 in rats caused by norethindrone or ethynyloestradiol.
    White IN; Muller-Eberhard U
    Biochem J; 1977 Jul; 166(1):57-64. PubMed ID: 901418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease.
    Andersen RN; Givens JR; Wiser WL; Umstot ES
    Am J Obstet Gynecol; 1976 May; 125(2):166-9. PubMed ID: 944533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutual modification of glucose-stimulated serum insulin responses in female rhesus monkeys by ethinyl estradiol and nortestosterone derivatives.
    Beck P; Venable RL; Hoff DL
    J Clin Endocrinol; 1975; 41(1):44-53. PubMed ID: 12334063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Insulin and proinsulin secretion under contraceptive steroid administration (author's transl)].
    Hausmann L; Goebel KM; Klähn D; Kaffarnik H
    Klin Wochenschr; 1975 Sep; 53(18):853-60. PubMed ID: 1165627
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate metabolism studies in women using Brevicon, a low-estrogen type of oral contraceptive, for one year.
    Spellacy WN; Buhi WC; Birk SA; Van Arnarn JB
    Am J Obstet Gynecol; 1982 Jan; 142(1):105-8. PubMed ID: 7034537
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbohydrate metabolism during treatment with estrogen, progestogen, and low-dose oral contraceptives.
    Spellacy WN
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):732-4. PubMed ID: 7039318
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of clofibrate on arginine-stimulated glucagon and insulin secretion in man.
    Eaton RP; Schade DS
    Metabolism; 1974 May; 23(5):445-54. PubMed ID: 4825301
    [No Abstract]   [Full Text] [Related]  

  • 40. Blood glucose and plasma insulin studies during three months' use of a low-estrogen type oral contraceptive.
    Spellacy WN; Buhi WC; Birk SA; Buggie J
    Fertil Steril; 1981 Jul; 36(1):68-70. PubMed ID: 7018930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.